🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, claiming the companies withheld alleged dangers that the pain reliever presented to pediatric brain development.

The court filing arrives a month after Donald Trump advocated an unsubstantiated connection between using Tylenol - also known as acetaminophen - during pregnancy and autism in young ones.

The attorney general is filing suit against Johnson & Johnson, which once produced the medication, the sole analgesic suggested for pregnant women, and Kenvue, which now manufacturers it.

In a statement, he claimed they "misled consumers by profiting off of discomfort and promoting medication ignoring the risks."

The manufacturer asserts there is insufficient reliable data linking acetaminophen to autism.

"These manufacturers deceived for years, intentionally threatening millions to boost earnings," Paxton, from the Republican party, said.

The company commented that it was "deeply concerned by the spread of false claims on the safety of paracetamol and the likely effects that could have on the health of American women and children."

On its online platform, Kenvue also mentioned it had "consistently assessed the pertinent research and there is lacking reliable evidence that indicates a proven link between consuming acetaminophen and autism."

Groups acting on behalf of medical professionals and medical practitioners concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to manage discomfort and elevated temperature, which can create serious health risks if not addressed.

"In over twenty years of studies on the utilization of acetaminophen in pregnancy, no reliable research has successfully concluded that the consumption of acetaminophen in any stage of pregnancy results in brain development issues in offspring," the group stated.

The court filing references latest statements from the former administration in arguing the drug is reportedly hazardous.

In recent weeks, the former president caused concern from public health officials when he told pregnant women to "resist strongly" not to take Tylenol when ill.

Federal regulators then published an announcement that medical professionals should contemplate reducing the usage of Tylenol, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary RFK Jr, who oversees the FDA, had vowed in April to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a short period.

But authorities advised that identifying a unique factor of autism spectrum disorder - considered by experts to be the result of a complex mix of inherited and environmental factors - would not be simple.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that affects how people encounter and interact with the surroundings, and is diagnosed using physician assessments.

In his court filing, Paxton - who supports Trump who is running for US Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

The lawsuit seeks to make the companies "eliminate any commercial messaging" that claims Tylenol is secure for expectant mothers.

The court case parallels the grievances of a assembly of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of Tylenol in recently.

Judicial authorities rejected the lawsuit, saying research from the parents' expert witnesses was lacking definitive proof.